Archive | Actos Litigation

Actos Whistle Blower Lawsuit Dismissed

A whistle-blower lawsuit filed by a former Takeda employee has been dismissed, according to Drug Watch. Dr. Helen Ge filed suit in 2010, arguing that Takeda officials had intentionally failed to report the dangerous side effects Actos to the FDA. Ge also alleged that Takeda “intentionally misrepresented and altered the descriptions of adverse events in […]

Read More »

Do You Know the Dangerous Side Effects of Actos?

Actos is used for the treatment and management of type 2 diabetes, but the Actos side effects can often be worse than the condition treated. Takeda Pharmaceuticals, the manufacturer of Actos, faces numerous lawsuits which allege that the company intentionally covered up critical facts about important side effects, including congestive heart failure, liver problems and […]

Read More »

Actos and Bladder Cancer – Lawsuits Continue to Mount

The evidence linking the type 2 diabetes drug Actos to bladder cancer continues to mount, and many Actos users suffering from the disease are taking action by filing lawsuits against Takeda Pharmaceuticals and Eli Lilly, the manufacturers of Actos. Actos (pioglitazone) is used along with diet and exercise—and sometimes other drugs—to keep type 2 diabetes […]

Read More »

Bladder Cancer Risk Factors and Actos Use

October 12, 2012  |   Posted by :   |   Actos Litigation,Actos Side Effects   |   0 Comments

If you or a loved one has been given a bladder cancer diagnosis after using Actos, know that you are not alone. Although studies have shown that this diabetes medication can significantly increase the risk of bladder cancer, Actos is still being sold and prescribed by doctors in the United States. In addition to the use […]

Read More »

Consumer Reports Urges Consumers to Stay Away From Actos

September 24, 2012  |   Posted by :   |   Actos Lawsuit,Actos Litigation,Actos Side Effects   |   0 Comments

Consumer Reports has recently reported that diabetic patients should avoid using Actos, unless other options have not worked. There are concerns regarding Actos use due to the increased risk for developing bladder cancer among patients that have used Actos.   side effects users of this prescription have experienced. While the FDA has issued warnings about Actos, […]

Read More »

New Study Reaffirms Link Between Actos and Bladder Cancer

The diabetes drug Actos has been linked to instances of bladder cancer in several studies, and it appears that the evidence of this link is mounting even more. Health Day now reports that a new study, published in the July 3rd issue of the Canadian Medical Association Journal, reaffirms this link and indicates that Actos […]

Read More »

Actos and Avandia Linked to Vision Problems

June 19, 2012  |   Posted by :   |   Actos Attorney,Actos Lawsuit,Actos Litigation,Actos Side Effects   |   0 Comments

British researchers are reporting that popular thiazolidinediones like Actos and Avandia may contribute to problems with eyesight. These drugs both have sordid histories, with Avandia being linked to elevated risk of heart attack, and Actos being linked to bladder cancer. These latest findings only exacerbate the controversies surrounding these drugs. Actos and Avandia are used […]

Read More »

Early Detection is Key in Treating Actos Bladder Cancer

It’s important that Actos users be able to recognize the symptoms of bladder cancer. The Type 2 diabetes drug Actos (pioglitazone) has been linked to an increased risk of certain complications, including bladder cancer. The key to treating bladder cancer successfully is catching the disease early and it’s important for Actos users to be able […]

Read More »

Protecting Your Health: What Actos Users Need to Know

Actos (pioglitazone) was first approved in 1999 for the treatment of Type 2 diabetes in adult patients. In recent years, the drug has been linked to an increased risk for certain complications, including the development of bladder cancer. If you have taken or are currently taking Actos, you need to know what you can do […]

Read More »

Doctors Group Advises Patients to Choose Alternatives to Actos

The American College of Physicians (ACP) has launched a new campaign advocating “high-value” care which recommends that patients who are newly diagnosed with diabetes seek out alternatives to Actos, Avandia and other name-brand diabetes medications.

Read More »